AiCuris Anti-infective Cures AG
- Address
- Friedrich-Ebert-Strasse 475, Elberfeld West
Sponsor Overview
Specializations
Antiviral Therapeutics
AiCuris Anti-infective Cures AG concentrates its research efforts on developing innovative treatments for viral infections. The company maintains an active portfolio of investigational therapies targeting specific viral pathogens that pose significant challenges in clinical medicine. Through its development programs, the organisation addresses unmet medical needs in the field of antiviral drug development, focusing on novel mechanisms of action and therapeutic approaches.
- Viral infection treatment strategies
- Novel antiviral compound development
- Pathogen-specific therapeutic interventions
The sponsor's research pipeline reflects a commitment to advancing anti-infective medicines through systematic clinical investigation across multiple international research sites, supporting the development of next-generation treatments for challenging viral diseases.
Infectious Disease Management
The company dedicates substantial resources to understanding and treating infectious diseases through comprehensive clinical research programs. AiCuris pursues therapeutic solutions that address both acute and chronic manifestations of microbial infections, with particular emphasis on conditions where current treatment options remain limited or where drug resistance presents clinical challenges.
- Anti-infective therapy optimization
- Pathogen-host interaction research
- Resistance mechanism investigation
The organisation's clinical trial activities span multiple countries, facilitating diverse patient recruitment and enabling robust evaluation of therapeutic efficacy across different populations affected by serious infectious conditions.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy and Safety Evaluation of Pritelivir in Immunocompromised Patients with Acyclovir-Resistant Mucocutaneous Herpes Simplex Virus Infections |  Belgium France Germany Greece Italy | Not Recruiting |
| Safety and Pharmacokinetics of AIC263029 in Patients with BKV-Associated Nephropathy: A Single and Multiple Dose Study | Germany | Not Recruiting |
Data & Insights
This sponsor works with 4 molecules, of which 2 are not being studied by other sponsors.
This sponsor has worked with 14 sites across their trial portfolio.
Therapeutic Focus
- 1.Virus Diseases2 trials182 other sponsors
Partnered Research Centres
14 centres- Address
- Deltalaan 1, 8800 Roeselare
- Address
- Ruddershove 10, 8000 Bruges
- Address
- 2 Avenue Martin Luther King, 87000 Limoges
- Address
- 1 Place Alexis Ricordeau, 44000 Nantes
- Address
- Grenadierstrasse 1, Neckarstadt, 68167 Berlin
- Address
- Via Francesco Sforza 28, 20122 Milan
Want to get in touch with this sponsor?
Send a question and we'll pass it on to AiCuris Anti-infective Cures AG.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.